Providing comprehensive psychosocial care for adolescents with keloids in dermatology practice

Kaitlyn Miner; Rachel Marciano; Andrew Pugliese; Sriya Kakarla; Jacquelyn Berman; Karen Gonzalez; Kelly Frasier; Belinda Mensah; Julia Vinagolu-Baur

doi:10.18203/issn.2455-4529.IntJResDermatol20250441

Authors

Kaitlyn Miner College of Medicine, Kansas City University, Kansas City, MO, USA
Rachel Marciano SUNY Upstate Medical University, Syracuse, New York, USA
Andrew Pugliese Touro College of Osteopathic Medicine, Middletown, New York, USA
Sriya Kakarla UTHealth Houston McGovern Medical School, Houston, Texas, USA
Jacquelyn Berman A.T. Still University School of Osteopathic Medicine in Arizona, Mesa, Arizona, USA
Karen Gonzalez SUNY Upstate Medical University, Syracuse, New York, USA
Kelly Frasier Department of Dermatology, Northwell Health, New Hyde Park, New York, USA
Belinda Mensah A.T. Still University School of Osteopathic Medicine in Arizona, Mesa, Arizona, USA
Julia Vinagolu-Baur SUNY Upstate Medical University, Syracuse, New York, USA

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20250441

Keywords:

Keloids, Anxiety, Depression

Abstract

Keloids, characterized by excessive collagen deposition resulting in raised and often painful scars, profoundly affect the psychosocial well-being of adolescents, leading to anxiety, depression, and social withdrawal during a critical period of identity formation. Current literature highlights these challenges but lacks comprehensive management strategies within dermatological practice. This review identifies the need for integrated care models that combine clinical treatment with mental health support, including routine psychosocial screening, immediate counseling referrals, and adolescent-specific education programs on keloid management and emotional coping. Training dermatologists to recognize psychological distress and adopt compassionate communication is essential. Collaborative research should focus on evaluating these integrative care models and developing evidence-based guidelines. By pioneering these comprehensive strategies, dermatology practices can improve physical outcomes and significantly enhance the quality of life for adolescents with keloids, addressing both the physical and psychological scars. Future research should prioritize the longitudinal impact of these interventions on mental health and treatment adherence, establishing a new standard of care that fully supports adolescent keloid patients. By implementing these comprehensive strategies, dermatology practices can enhance physical outcomes and significantly improve the quality of life for adolescents with keloids, addressing both the physical and psychological impacts in the management of keloids in this vulnerable population.

Metrics

Metrics Loading ...

References

Huang C, Wu Z, Du Y, Ogawa R. The Epidemiology of Keloids. Textbook on Scar Management: State of the Art Management and Emerging Technologies. Springer. 2020;29-35. DOI: https://doi.org/10.1007/978-3-030-44766-3_4

Juckett G, Hartman-Adams H. Management of Keloids and Hypertrophic Scars. Am Fam Physician. 2009;80(3):253-60.

McGinty S, Siddiqui WJ. Keloid. In StatPearls. StatPearls Publishing. 2023.

Shaheen A. Risk Factors of Keloids: A Mini Review. Austin J Dermatol. 2017;(4)2. DOI: https://doi.org/10.26420/austinjdermatolog.2017.1074

Moreno Pizarro E, Morales Valencia E, Pérez Cuéllar A, Acuña Pinzon C, Serrano Padilla AE. Monoclonal Antibodies Addressed to Factors of Signalization in Keloid Scars: Opportunities and Areas of Action. Cureus. 2020;12(6):e8894.

Patrick DL, Topolski TD, Edwards TC, Aspinall CL, Kapp-Simon KA, Rumsey NJ, et al. Measuring the quality of life of youth with facial differences. Cleft Palate Craniofac J. 2007;44(5):538-47. DOI: https://doi.org/10.1597/06-072.1

Olaitan PB. Keloids: assessment of effects and psychosocial-impacts on subjects in a black African population. Indian J Dermatol Venereol Leprol. 2009;75(4):368-72. DOI: https://doi.org/10.4103/0378-6323.53132

Bijlard E, Kouwenberg CA, Timman R, Hovius SE, Busschbach JJ, Mureau MA. Burden of Keloid Disease: A Cross-sectional Health-related Quality of Life Assessment. Acta Derm Venereol. 2017;97(2):225-9. DOI: https://doi.org/10.2340/00015555-2498

Shih B, Bayat A. Genetics of keloid scarring. Arch Dermatol Res. 2010;302(5):319-39. DOI: https://doi.org/10.1007/s00403-009-1014-y

Tan S, Khumalo N, Bayat A. Understanding Keloid Pathobiology From a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease With Cancer-Like Tendencies. Front Immunol. 2019;10:1810. DOI: https://doi.org/10.3389/fimmu.2019.01810

Zhang M, Chen H, Qian H, Wang C. Characterization of the skin keloid microenvironment. Cell Commun Signal. 2023;21(1):207. DOI: https://doi.org/10.1186/s12964-023-01214-0

Niu X, Lin X, Chen X, Xu S, Huang Z, Tang Q. Long-wave Ultraviolet Ray Promotes Inflammation in Keloid-derived Fibroblasts by Activating P38-NFκB1 Signaling Pathway. J Burn Care Res. 2020;41(6):1231-9. DOI: https://doi.org/10.1093/jbcr/iraa075

Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17(1-2):113-25. DOI: https://doi.org/10.2119/molmed.2009.00153

Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S. The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models. Front Cell Dev Biol. 2020;8:360. DOI: https://doi.org/10.3389/fcell.2020.00360

Tsai CH, Ogawa R. Keloid research: current status and future directions. Scars Burn Heal. 2019;5:2059513119868659. DOI: https://doi.org/10.1177/2059513119868659

Lu W, Chu H, Zheng X. Effects on quality of life and psychosocial wellbeing in Chinese patients with keloids. Am J Transl Res. 2021;13(3):1636-42.

Anaba E, Cole-Adeife O. Keloid disease: Prospective cross-sectional study of clinicoepidemiological and health related quality of life at a tertiary center. Ann Clin Sci. 2023;(8)1:20-7.

Paller AS, Rangel SM, Chamlin SL, Hajek A, Phan S, Hogeling M, et al; Pediatric Dermatology Research Alliance. Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders. JAMA Dermatol. 2024;160(6):621-30. DOI: https://doi.org/10.1001/jamadermatol.2024.0594

Vivar KL, Kruse L. The impact of pediatric skin disease on self-esteem. Int J Womens Dermatol. 2017;4(1):27-31. DOI: https://doi.org/10.1016/j.ijwd.2017.11.002

Awosika O, Burgess CM, Grimes PE. Considerations When Treating Cosmetic Concerns in Men of Color. Dermatol Surg. 2017;43(2):S140-50. DOI: https://doi.org/10.1097/DSS.0000000000001376

Garg SP, Hassan AM, Patel A, Koko D, Varghese J, Ellis MF, et al. Scar Perception: A Comparison of African American and White Self-identified Patients. Plast Reconstr Surg Glob Open. 2022;10(5):e4345. DOI: https://doi.org/10.1097/GOX.0000000000004345

Tat S, Eshiobo I. Unusually Located Keloids—The Role of Cultural Practices in its Etiology. J Clin Exp Dermatol. 2011;02:05. DOI: https://doi.org/10.4172/2155-9554.1000128

Poetschke J, Reinholz M, Schwaiger H, Epple A, Gauglitz GG. DLQI and POSAS Scores in Keloid Patients. Facial Plast Surg. 2016;32(3):289-95. DOI: https://doi.org/10.1055/s-0036-1583851

Sitaniya S, Subramani D, Jadhav A, Sharma YK, Deora MS, Gupta A. Quality-of-life of people with keloids and its correlation with clinical severity and demographic profiles. Wound Repair Regen. 2022;30(3):409-16. DOI: https://doi.org/10.1111/wrr.13015

Gold MH, Foster TD, Adair MA, Burlison K, Lewis T. Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol Surg. 2001;27(7):641-4. DOI: https://doi.org/10.1046/j.1524-4725.2001.00356.x

Puri N, Talwar A. The efficacy of silicone gel for the treatment of hypertrophic scars and keloids. J Cutan Aesthet Surg. 2009;2(2):104-6. DOI: https://doi.org/10.4103/0974-2077.58527

Darzi MA, Chowdri NA, Kaul SK, Khan M. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg. 1992;45(5):374-9. DOI: https://doi.org/10.1016/0007-1226(92)90008-L

Wu W, Zhao Y, Chen Y, Zhong A. Comparing the Efficacy of Multiple Drugs Injection for the Treatment of Hypertrophic Scars and Keloid: A Network Meta-Analysis. Aesthetic Plast Surg. 2023;47(1):465-72. DOI: https://doi.org/10.1007/s00266-022-03163-4

Forbat E, Ali FR, Al-Niaimi F. Treatment of keloid scars using light-, laser- and energy-based devices: a contemporary review of the literature. Lasers Med Sci. 2017;32(9):2145-54. DOI: https://doi.org/10.1007/s10103-017-2332-5

McGoldrick RB, Theodorakopoulou E, Azzopardi EA, Murison M. Lasers and ancillary treatments for scar management Part 2: Keloid, hypertrophic, pigmented and acne scars. Scars Burn Heal. 2017;3:2059513116689805. DOI: https://doi.org/10.1177/2059513116689805

Moreno Pizarro E, Morales Valencia E, Pérez Cuéllar A, Acuña Pinzon C, Serrano Padilla AE. Monoclonal Antibodies Addressed to Factors of Signalization in Keloid Scars: Opportunities and Areas of Action. Cureus. 2020;12(6):e8894. DOI: https://doi.org/10.7759/cureus.8894

Rauch PK, Jellinek MS, Murphy JM, Schachner L, Hansen R, Esterly NB, et al. Screening for psychosocial dysfunction in pediatric dermatology practice. Clin Pediatr (Phila). 1991;30(8):493-7. DOI: https://doi.org/10.1177/000992289103000807

Chouliara Z, Stephen K, Buchanan P. The importance of psychosocial assessment in dermatology: Opening Pandora’s Box? Dermatol Nurs. 2017;(16)4:30-4.

Heijnders M, Van Der Meij S. The fight against stigma: an overview of stigma-reduction strategies and interventions. Psychol Health Med. 2006;11(3):353-63. DOI: https://doi.org/10.1080/13548500600595327

Furtado F, Hochman B, Farber PL, Muller MC, Hayashi LF, Ferreira LM. Psychological stress as a risk factor for postoperative keloid recurrence. J Psychosom Res. 2012;72(4):282-7. DOI: https://doi.org/10.1016/j.jpsychores.2011.12.010

Germain N, Augustin M, François C, Legau K, Bogoeva N, Desroches M, et al. Stigma in visible skin diseases - a literature review and development of a conceptual model. J Eur Acad Dermatol Venereol. 2021;35(7):1493-504. DOI: https://doi.org/10.1111/jdv.17110

Rieder EA, Andriessen A, Cutler V, Gonzalez ME, Greenberg JL, Lio P, et al. Dermatology in Contemporary Times: Building Awareness of Social Media's Association With Adolescent Skin Disease and Mental Health. J Drugs Dermatol. 2023;22(8):817-25. DOI: https://doi.org/10.36849/jdd.7596

Shah KN, Cortina S, Ernst MM, Kichler JC. Psoriasis in childhood: effective strategies to improve treatment adherence. Psoriasis (Auckl). 2015;5:43-54. DOI: https://doi.org/10.2147/PTT.S54090

Marzban S, Najafi M, Agolli A, Ashrafi E. Impact of Patient Engagement on Healthcare Quality: A Scoping Review. J Patient Exp. 2022;9:23743735221125439. DOI: https://doi.org/10.1177/23743735221125439

Bewley A, Taylor RE, Reichenberg JS, Magid M. Practical Psychodermatology. Wiley-Blackwell. 2014. DOI: https://doi.org/10.1002/9781118560648

Freedman S, Golberstein E, Huang TY, Satin DJ, Smith LB. Docs with their eyes on the clock? The effect of time pressures on primary care productivity. J Health Econ. 2021;77:102442. DOI: https://doi.org/10.1016/j.jhealeco.2021.102442

Davern J, O'Donnell AT. Stigma predicts health-related quality of life impairment, psychological distress, and somatic symptoms in acne sufferers. PLoS One. 2018;13(9):e0205009. DOI: https://doi.org/10.1371/journal.pone.0205009

Nagpal N, Gordon-Elliott J, Lipner S. Comparison of quality of life and illness perception among patients with acne, eczema, and psoriasis. Dermatol Online J. 2019;25(5):13030. DOI: https://doi.org/10.5070/D3255044060

Tang TR, Wang M, Li H, Yang SC, Zhang CC, Lin WR, et al. Untreated depression and anxiety in patients with common skin diseases: a cross-sectional study in China. Front Psychol. 2023;14:1150998. DOI: https://doi.org/10.3389/fpsyg.2023.1150998

Dreno B, Amici JM, Demessant-Flavigny AL, Wright C, Taieb C, Desai SR, et al. The Impact of Acne, Atopic Dermatitis, Skin Toxicities and Scars on Quality of Life and the Importance of a Holistic Treatment Approach. Clin Cosmet Investig Dermatol. 2021;14:623-32. DOI: https://doi.org/10.2147/CCID.S315846

Nguyen CM, Koo J, Cordoro KM. Psychodermatologic Effects of Atopic Dermatitis and Acne: A Review on Self-Esteem and Identity. Pediatr Dermatol. 2016;33(2):129-35. DOI: https://doi.org/10.1111/pde.12802

Magin P, Adams J, Heading G, Pond D, Smith W. Experiences of appearance-related teasing and bullying in skin diseases and their psychological sequelae: results of a qualitative study. Scand J Caring Sci. 2008;22(3):430-6. DOI: https://doi.org/10.1111/j.1471-6712.2007.00547.x

Kim M, Mirsky N, Spielman A, Mathew P, Yechieli R, Tang JC, et al. Evaluating Symptomatic and Psychosocial Well-being After Keloid Treatment With SCAR-Q. Aesthet Surg J. 2022;42(6):NP416-22. DOI: https://doi.org/10.1093/asj/sjac043

Ahad AA, Sanchez-Gonzalez M, Junquera P. Understanding and Addressing Mental Health Stigma Across Cultures for Improving Psychiatric Care: A Narrative Review. Cureus. 2023;15(5):e39549. DOI: https://doi.org/10.7759/cureus.39549

Ud-Din S, Bayat A. Strategic management of keloid disease in ethnic skin: a structured approach supported by the emerging literature. Br J Dermatol. 2013;169(3):71-81. DOI: https://doi.org/10.1111/bjd.12588

Akeju DO, Okusanya BO, Ukah UV, Orimaye SO, Dirisu O. Editorial: Policy issues and perspectives in referrals and access to quality health care services. Front Health Serv. 2023;3:1323442. DOI: https://doi.org/10.3389/frhs.2023.1323442

Shah RB. Impact of collaboration between psychologists and dermatologists: UK hospital system example. Int J Womens Dermatol. 2017;4(1):8-11. DOI: https://doi.org/10.1016/j.ijwd.2017.10.003